NPI registry status
Active
2026 NPPES data Nephrology Physician NPI 1720343783 MD
Verify on CMS → Avantika Chenna, MD
Nephrology Physician in Bloomington, Indiana.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 10,569 in Nephrology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
1K
Medicare Part D claims · 250 beneficiaries · Nephrology Physician avg: 1K
Generic prescribing
91%
generic claims · 9% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
10.9/100
▼ 72 pts below national avg 83.1 · Penalty band
Industry payments
$82.46
1 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Avantika Chenna, MD reported a CMS MIPS final score of 10.9/100 - below the 83.1 national average - and filed 1,135 Medicare Part D claims in 2023.
- 10.9/100
- MIPS score · -72 vs avg
- 1K
- Part D claims, 2023
- 91%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Avantika Chenna, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
11 2nd percentile higher than 2% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Avantika Chenna, MD sits
This provider among nephrology physician peers
Across the 2,476 nephrology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Avantika Chenna, MD writes more Part D claims than 51% of them and scores higher on MIPS quality than 2% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one nephrology physician peer from a representative sample of 60; the gold marker is Avantika Chenna, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Avantika Chenna, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Avantika Chenna, MD?
Below national averagePrimary specialty
Nephrology Physician
Medicare Part D claims
1,135 22% vs specialty avg
MIPS final score
10.9/100 72.2 pts vs avg
Specialty distribution in Indiana
How Nephrology Physician compares to other specialties among Indiana providers
Medicare quality performance, MIPS
Avantika Chenna, MD's 2023 MIPS final score plotted against the Nephrology Physician national average
- MIPS Final Score
- 10.9/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Nephrology Physician) - 10.9/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Avantika Chenna, MD appears in the CMS NPPES registry as a Nephrology Physician provider holding MD credentials at 550 S LANDMARK AVE, Bloomington, IN, 47403, with a listed phone of (812) 676-4660. NPI 1720343783 was issued on 07/05/2012.
Medicare Part D records for calendar year 2023 show 1,135 prescription claims written by this provider, covering 250 Medicare beneficiaries and totaling roughly $132K in drug spend, split 9% brand-name and 91% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 10.9/100 for the 2023 performance year (Quality 0, Cost 36.3), compared with the national average of 83.1.
Nephrology Physician is a mid-sized specialty nationwide, with 10,569 enrolled providers across 55 states and an average of 1,454 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1720343783 |
|---|---|
| Specialty | Nephrology Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 07/05/2012 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
10.8752
Final Score
Avg: 83.1
0
Quality
36.2508
Cost
0
Promoting Interoperability
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Avantika Chenna, MD. Source: openpaymentsdata.cms.gov.
Total received
$82
Largest payer
Boston Scientific Corporation
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Generic-heavy
Avantika Chenna, MD - brand share 9.0%
Nephrology Physician average
9% brand-name claims vs 91% generic, on 1,135 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
1,135
Total Claims
$132K
Total Drug Cost
250
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 2,446
- Total Day Supply
- 71,521
- Brand vs Generic
- 9% brand / 91% generic
- Brand Drug Cost
- $104K
- Generic Drug Cost
- $28K
- Antibiotic Claims
- 52
Patient Demographics
- Average Patient Age
- 72.3 years
- Avg HCC Risk Score
- 3.30
- Gender Split
- 58% female / 42% male
- Age Distribution
- <65: 35, 65-74: 109, 75-84: 79, 85+: 27
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Avantika Chenna, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Furosemide
Furosemide
122 claims
- Amlodipine Besylate
Amlodipine Besylate
92 claims
- Losartan Potassium
Losartan Potassium
87 claims
- Torsemide
Torsemide
85 claims
- Carvedilol
Carvedilol
79 claims
- Calcitriol
Calcitriol
74 claims
- Hydralazine Hcl
Hydralazine Hcl
58 claims
- Lisinopril
Lisinopril
52 claims
| Drug | Claims |
|---|---|
| Furosemide | 122 |
| Amlodipine Besylate | 92 |
| Losartan Potassium | 87 |
| Torsemide | 85 |
| Carvedilol | 79 |
| Calcitriol | 74 |
| Hydralazine Hcl | 58 |
| Lisinopril | 52 |
| Spironolactone | 50 |
| Farxiga Dapagliflozin Propanediol | 34 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Nephrology Physician Overview
How Avantika Chenna, MD fits within the Nephrology Physician landscape nationally.
10,569
Nephrology Physician Providers in US
55
States with Nephrology Physician
1,454
Avg Claims per Provider
Avantika Chenna, MD's 1,135 claims are below the specialty average of 1,454.
Nearby Nephrology Physician Providers in Indiana
Other clinicians with the same primary specialty enrolled in Indiana, drawn from the same CMS NPPES roster as Chenna.
Nabigha Abdul Baki
Indianapolis, IN
Dr. Raied Abdullah
M.D.
Gary, IN
Dr. Stuart Abramson
MD
Indianapolis, IN
Roulan Abu Hweij
Danville, IN
Dr. Rajiv Agarwal
M.D.
Indianapolis, IN
Compare Nephrology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Indiana medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Nephrology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Indiana
Frequently Asked Questions
What is Avantika Chenna, MD's specialty? ▼
Avantika Chenna, MD specializes in Nephrology Physician and practices in Bloomington, Indiana. Credentials: MD.
How much does Avantika Chenna, MD prescribe under Medicare Part D? ▼
In 2023, Avantika Chenna, MD wrote 1,135 Medicare Part D claims totaling $132K in drug costs for 250 beneficiaries.
What is Avantika Chenna, MD's Medicare quality score? ▼
Avantika Chenna, MD has a CMS MIPS Final Score of 10.9/100 (Quality: 0, Cost: 36.3). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Avantika Chenna, MD located? ▼
Avantika Chenna, MD is located at 550 S LANDMARK AVE, Bloomington, IN, 47403. Phone: (812) 676-4660.
What is Avantika Chenna, MD's NPI number? ▼
Avantika Chenna, MD's National Provider Identifier (NPI) is 1720343783, issued on 07/05/2012.
Does Avantika Chenna, MD prescribe more brand-name or generic drugs? ▼
Avantika Chenna, MD's prescribing is 9% brand-name and 91% generic drugs by claim count, with $104K in brand drug costs.
How many Nephrology Physician providers are there in the US? ▼
There are 10,569 Nephrology Physician providers across 55 states in the US. The average Nephrology Physician provider writes 1,454 Medicare Part D claims per year.
What drugs does Avantika Chenna, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Avantika Chenna, MD's most frequently prescribed drugs include Furosemide, Amlodipine Besylate, Losartan Potassium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Avantika Chenna, MD accept Medicare? ▼
Avantika Chenna, MD appears in CMS Medicare data with 1,135 Part D claims and 250 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Avantika Chenna, MD's credentials? ▼
Avantika Chenna, MD's NPI is 1720343783 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.